- Too hot by day, Dubai's floodlit beaches are packed at night
- Is music finally reckoning with #MeToo?
- Fans hail Trump's 'guts' as he returns to site of rally shooting
- Lebanon state media says 'very violent' Israeli strikes hit south Beirut
- Guardians maul Tigers, miracle Mets rally in MLB series openers
- Lebanon state media says Israeli strikes hit south Beirut
- Miami on track for MLS record points after win in Toronto
- Madrid beat Villarreal but Carvajal suffers knee injury
- Madrid beat Villarreal to move level with Liga leaders Barcelona
- Monaco take top spot in Ligue 1 with win at Rennes
- French rugby player on rape charge whistled but 'serene' on return
- Madrid beat Villarreal to level Liga leaders Barca
- Thuram treble fires Inter past Torino and up to second
- 'Fight': defiant Trump jets in to site of rally shooting
- Toddler among 3 dead in migrant Channel crossings
- Mexico City's new mayor sworn in with pledges on water, housing
- Israel on alert ahead of Hamas attack anniversary
- Guardians maul Tigers in MLB playoff series opener
- Macron criticises Israel on Gaza, Lebanon operations
- French rugby player whistled but 'serene' on return amid ongoing rape case
- Kovacic stars as Man City sink Fulham to get title bid back on track
- Retegui hat-trick fires five-star Atalanta to hammering of Genoa
- Heavyweights Australia, England off to World Cup winning starts
- Visiting UN refugee agency chief decries 'terrible crisis' in Lebanon
- Spinners come to party as England defeat Bangladesh at T20 World Cup
- Search continues for missing in deadly Bosnia floods
- Man City sink Fulham to get title bid back on track
- France's Auradou whistled on Pau return in Perpignan loss amid ongoing rape case
- A 'forgotten' valley in storm-hit North Carolina, desperate for help
- Arsenal hit back in style after Southampton scare
- Thousands march for Palestinians ahead of Oct 7 anniversary
- Hezbollah heir apparent Safieddine out of contact after strikes
- Liverpool stay top of Premier League as Arsenal, Man City win
- In dank Tour of Emilia, Pogacar shines in rainbow jersey
- DR Congo launches mpox vaccination drive, hoping to curb outbreak
- Trump returns to site of failed assassination
- Careless Leverkusen held to Bundesliga draw
- O'Brien's 'superstar' Kyprios posts landmark win on Arc weekend
- Toddler crushed to death in migrant Channel crossing
- Liverpool suffer Alisson injury blow
- Habosi helps Racing beat Vannes before Auradou's playing return
- Thousands march in London in support of Palestinians, 1 year after Oct 7
- Israel readying response to Iran missile attack
- Schutt, Mooney help Australia beat Sri Lanka in Women's T20 World Cup
- Liverpool extend Premier League lead with win at Palace
- Djokovic 'shakes rust off' to make third round of Shanghai Masters
- 'Imperfect' PSG fighting on all fronts - Luis Enrique
- Struggling Pakistan look to thwart adaptable England
- Child 'trampled to death' in asylum seekers' Channel crossing: minister
- Gauff fights back to set up Beijing final against Muchova
Pharma firm urged to share new 'game-changer' HIV drug
More than 300 politicians, health experts and celebrities on Thursday called for US pharmaceutical giant Gilead to allow cheap, generic versions of a promising new HIV drug to be produced so it can reach people in developing countries most affected by the deadly disease.
The drug Lenacapavir could be a "real game-changer" in the fight against HIV, according to an open letter to Gilead CEO Daniel O'Day signed by a range of former world leaders, AIDS groups, activists, actors and others.
Lenacapavir, which was approved for use in the United States and the European Union in 2022, only needs to be injected twice a year, making it particularly suited for people normally "excluded from high quality healthcare," the open letter said.
"We urge Gilead to ensure that people in the Global South living with or at risk of HIV can access this groundbreaking medicine at the same time as people in the Global North can," it added.
The signatories urged Gilead to licence the drug on the United Nations-backed Medicines Patent Pool, which would allow for cheaper generic versions to be manufactured.
Two thirds of the 39 million people living with HIV were in Africa in 2022, according to the World Health Organization. Africa also accounted for 380,000 of the 630,000 AIDS-related deaths across the world that year, the WHO figures showed.
- 'Horror and shame' -
The letter said the "world now recalls with horror and shame that it took 10 years and 12 million lives lost before generic versions" of the first antiretroviral drugs became available worldwide.
"This innovation could help end AIDS as a public health threat by 2030 – but only if all who would benefit from it can access it."
Because it only requires two shots a year, the drug could be particularly important for those who face stigma getting treated for HIV, including young women, LGBTQ people, sex workers and people who inject drugs, the letter said.
Among the signatories were former heads of state including Liberian ex-president Ellen Johnson Sirleaf and Milawi's Joyce Banda.
UNAIDS executive director Winnie Byanyima and other humanitarian figures also signed on, as did actors including Gillian Anderson, Stephen Fry, Sharon Stone and Alan Cummings.
Another signatory Francoise Barre-Sinoussi -- the French scientist who co-discovered the HIV virus -- lamented "that inequality, not science, is the greatest barrier to fighting AIDS".
On behalf of the scientists who paved the way for such new medicine, "I implore Gilead to erase much of that inequality and make a monumental step towards ending the AIDS pandemic," she said in a statement.
Lenacapavir, sold under the brand name Sunlenca, has been shown to reduce "viral load in patients with infections that are resistant to other treatments," according to the European Medicines Agency.
D.Sawyer--AMWN